<VariationArchive VariationID="521067" VariationName="NM_000275.3(OCA2):c.131del (p.Gly44fs)" VariationType="Deletion" Accession="VCV000521067" Version="10" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-23" DateCreated="2018-04-15" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="512126" VariationID="521067">
      <GeneList>
        <Gene Symbol="OCA2" FullName="OCA2 melanosomal transmembrane protein" GeneID="4948" HGNC_ID="HGNC:8101" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q12-13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="27719008" stop="28099315" display_start="27719008" display_stop="28099315" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NT_187660.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NW_011332701.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="28000020" stop="28344457" display_start="28000020" display_stop="28344457" Strand="-" />
          </Location>
          <OMIM>611409</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000275.3(OCA2):c.131del (p.Gly44fs)</Name>
      <CanonicalSPDI>NC_000015.10:28081743:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="28081744" stop="28081744" display_start="28081744" display_stop="28081744" variantLength="1" positionVCF="28081743" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="28326890" stop="28326890" display_start="28326890" display_stop="28326890" variantLength="1" positionVCF="28326889" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G44fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.28081745del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.28081745del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.28326891del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.28326891del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009846.1" sequenceAccession="NG_009846" sequenceVersion="1" change="g.22569del">
            <Expression>NG_009846.1:g.22569del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000275.3" sequenceAccession="NM_000275" sequenceVersion="3" change="c.131del" MANESelect="true">
            <Expression>NM_000275.3:c.131del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000266.2" sequenceAccession="NP_000266" sequenceVersion="2" change="p.Gly44fs">
            <Expression>NP_000266.2:p.Gly44fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001300984.2" sequenceAccession="NM_001300984" sequenceVersion="2" change="c.131del">
            <Expression>NM_001300984.2:c.131del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001287913.1" sequenceAccession="NP_001287913" sequenceVersion="1" change="p.Gly44fs">
            <Expression>NP_001287913.1:p.Gly44fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA7439571" DB="ClinGen" />
        <XRef Type="rs" ID="780625433" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000275.3(OCA2):c.131del (p.Gly44fs) AND Inborn genetic diseases" Accession="RCV000622436" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-06-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000275.3(OCA2):c.131del (p.Gly44fs) AND not provided" Accession="RCV001860430" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000275.3(OCA2):c.131del (p.Gly44fs) AND Tyrosinase-positive oculocutaneous albinism" Accession="RCV002282270" Version="3">
        <ClassifiedConditionList TraitSetID="250">
          <ClassifiedCondition DB="MedGen" ID="C0268495">Tyrosinase-positive oculocutaneous albinism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-07-15" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000275.3(OCA2):c.131del (p.Gly44fs) AND SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES" Accession="RCV003465356" Version="2">
        <ClassifiedConditionList TraitSetID="252">
          <ClassifiedCondition DB="MedGen" ID="C1856895">SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-23" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2018-04-15" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10094567</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15712365</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19865097</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21541274</ID>
        </Citation>
        <DescriptionHistory Dated="2024-04-20">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="252" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4148" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Skin/hair/eye pigmentation, variation in, 1</ElementValue>
                <XRef ID="Skin-hair-eye+pigmentation%2C+variation+in%2C+1/9304" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BROWN EYE COLOR 2</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EYE COLOR 3</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EYE COLOR, BLUE/NONBLUE</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EYE COLOR, BROWN/BLUE</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HAIR COLOR 3</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SKIN/HAIR/EYE PIGMENTATION 1, BLOND/BROWN HAIR</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611409.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605837.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SKIN/HAIR/EYE PIGMENTATION 1, BLUE/BROWN EYES</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611409.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611409.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605837.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611409.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605837.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611409.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605837.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611409.0013" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BEY2</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EYCL3</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HCL3</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SHEP1</ElementValue>
                <XRef Type="MIM" ID="227220" DB="OMIM" />
              </Symbol>
              <XRef ID="C1856895" DB="MedGen" />
              <XRef Type="MIM" ID="227220" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="250" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="198" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Albinism 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinoidism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism, oculocutaneous, type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tyrosinase-positive oculocutaneous albinism</ElementValue>
                <XRef ID="Oculocutaneous+albinism+type+2/5317" DB="Genetic Alliance" />
                <XRef ID="26336006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALBINISM II</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OCA2</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4038" />
                <XRef ID="4038" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">37053367</ID>
                <ID Source="BookShelf">NBK590568</ID>
              </Citation>
              <XRef ID="79432" DB="Orphanet" />
              <XRef ID="C0268495" DB="MedGen" />
              <XRef ID="MONDO:0008746" DB="MONDO" />
              <XRef Type="MIM" ID="203200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5026149" SubmissionDate="2022-09-08" DateLastUpdated="2022-09-17" DateCreated="2022-09-17">
        <ClinVarSubmissionID localKey="NM_000275.3:c.131del|OMIM:203200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002570389" DateUpdated="2022-09-17" DateCreated="2022-09-17" Type="SCV" Version="1" SubmitterName="Johns Hopkins Genomics, Johns Hopkins University" OrgID="506823" OrganizationCategory="laboratory" OrgAbbreviation="JHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10094567</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15712365</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21541274</ID>
          </Citation>
          <Comment>This OCA2 variant (rs780625433) is rare (&lt;0.1%) in a large population dataset (gnomAD: 6/276568 total alleles; 0.002%; no homozygotes) and has been reported in ClinVar. This frameshift variant (p.Gly44fs) in exon 2 of 24 results in a premature termination signal likely leading to nonsense-mediated decay and lack of protein production. Bioinformatic analysis predicts the co-occurrence of this variant on the same haplotype as c.1103C&gt;T, although this has not been confirmed experimentally to our knowledge. We consider c.131del to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000275.3:c.131del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="203200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12035625</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1445281" SubmissionDate="2020-10-09" DateLastUpdated="2023-01-07" DateCreated="2018-04-15">
        <ClinVarSubmissionID localKey="a394409" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000741489" DateUpdated="2023-01-07" DateCreated="2018-04-15" Type="SCV" Version="3" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry exome assertion method (8-5-2015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/xlwdlsvu/ambry_exome_assertion_method_8-5-2015_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>African American/Caucasian/Hispanic/Native American/Jamaican</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <FamilyData PedigreeID="a924607" />
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Horizontal nystagmus</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000666" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Hypopigmentation of the skin</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001010" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Fair hair</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002286" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Hypermetropia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000540" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Albinism</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001022" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000275.2:c.131delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MeSH" ID="D030342" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
          <SubmissionName>exome clinvar deposit 2.18.18</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4202396" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13425700|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002180582" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19865097</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21541274</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly44Glufs*58) in the OCA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OCA2 are known to be pathogenic (PMID: 19865097, 21541274). This variant is present in population databases (rs780625433, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with OCA2-related conditions. ClinVar contains an entry for this variant (Variation ID: 521067). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.28326890del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9057076" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="74851058|Orphanet:ORPHA79432" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004848054" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely Pathogenic</GermlineClassification>
          <Comment>The p.Gly44GlufsX58 variant in OCA2 has not been previously reported in individuals with disease but has been identified in 0.045% (4/8956) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 44 and leads to a premature termination codon 58 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Biallelic loss of function of the OCA2 gene is an established disease mechanism for oculocutaneous albinism type 2. In summary, although additional studies are required to fully establish its clinical significance, the p.Gly44GlufsX58 variant is likely pathogenic based upon predicted impact to the gene.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000275.3:exon 2</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.10:g.28081744delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA79432" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7855759" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000275.3:c.131del|OMIM:227220" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004209036" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000275.3:c.131del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="227220" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4202396" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445281" TraitType="Finding" MappingType="Name" MappingValue="Fair hair" MappingRef="Preferred">
        <MedGen CUI="C1849221" Name="Fair hair" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9057076" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA79432" MappingRef="Orphanet">
        <MedGen CUI="C0268495" Name="Tyrosinase-positive oculocutaneous albinism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445281" TraitType="Finding" MappingType="Name" MappingValue="Horizontal nystagmus" MappingRef="Preferred">
        <MedGen CUI="C0271385" Name="Horizontal nystagmus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445281" TraitType="Disease" MappingType="XRef" MappingValue="D030342" MappingRef="MeSH">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7855759" TraitType="Disease" MappingType="XRef" MappingValue="227220" MappingRef="OMIM">
        <MedGen CUI="C1856895" Name="SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445281" TraitType="Finding" MappingType="Name" MappingValue="Hypopigmentation of the skin" MappingRef="Preferred">
        <MedGen CUI="C0162835" Name="Hypopigmentation of the skin" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445281" TraitType="Finding" MappingType="Name" MappingValue="Albinism" MappingRef="Preferred">
        <MedGen CUI="C0001916" Name="Albinism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5026149" TraitType="Disease" MappingType="XRef" MappingValue="203200" MappingRef="OMIM">
        <MedGen CUI="C0268495" Name="Tyrosinase-positive oculocutaneous albinism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445281" TraitType="Finding" MappingType="Name" MappingValue="Hypermetropia" MappingRef="Preferred">
        <MedGen CUI="C0020490" Name="Hypermetropia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

